Masood A. Khan

1.3k total citations
44 papers, 1.0k citations indexed

About

Masood A. Khan is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Masood A. Khan has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 9 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in Masood A. Khan's work include Prostate Cancer Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (31 papers) and Urologic and reproductive health conditions (9 papers). Masood A. Khan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (31 papers) and Urologic and reproductive health conditions (9 papers). Masood A. Khan collaborates with scholars based in United Kingdom, United States and Pakistan. Masood A. Khan's co-authors include Alan W. Partin, Jonathan I. Epstein, Patrick C. Walsh, Leslie A. Mangold, Robert W. Veltri, Michael Craig Miller, A. Graham Pockley, Raj P. Pal, Georgina Cosma and David J. Brown and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Masood A. Khan

43 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masood A. Khan United Kingdom 18 720 193 147 146 138 44 1.0k
Ugo Giovanni Falagario Italy 19 867 1.2× 264 1.4× 167 1.1× 362 2.5× 142 1.0× 120 1.2k
Pieter De Visschere Belgium 19 1.3k 1.8× 436 2.3× 169 1.1× 199 1.4× 111 0.8× 64 1.6k
Sanoj Punnen United States 16 570 0.8× 120 0.6× 55 0.4× 163 1.1× 87 0.6× 58 790
Peter Swindle Australia 13 984 1.4× 308 1.6× 220 1.5× 170 1.2× 124 0.9× 16 1.3k
Paula Kujala Finland 19 589 0.8× 99 0.5× 285 1.9× 168 1.2× 282 2.0× 69 994
Nelly Tan United States 19 990 1.4× 316 1.6× 74 0.5× 162 1.1× 164 1.2× 64 1.4k
Kerri Cote United States 16 1.0k 1.4× 159 0.8× 158 1.1× 215 1.5× 65 0.5× 22 1.2k
Seungtaek Choi United States 21 1.1k 1.5× 77 0.4× 103 0.7× 148 1.0× 35 0.3× 71 1.3k
John J. Bauer United States 19 1.4k 2.0× 214 1.1× 320 2.2× 417 2.9× 408 3.0× 51 1.9k
John Foley United States 14 668 0.9× 167 0.9× 101 0.7× 129 0.9× 79 0.6× 20 859

Countries citing papers authored by Masood A. Khan

Since Specialization
Citations

This map shows the geographic impact of Masood A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masood A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masood A. Khan more than expected).

Fields of papers citing papers by Masood A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masood A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masood A. Khan. The network helps show where Masood A. Khan may publish in the future.

Co-authorship network of co-authors of Masood A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Masood A. Khan. A scholar is included among the top collaborators of Masood A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masood A. Khan. Masood A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Rabbiya, et al.. (2024). Exploring Patient Safety Culture: A Study of Community Pharmacies in Karachi, Pakistan. Cureus. 16(1). e52135–e52135.
2.
3.
4.
Khan, Masood A., et al.. (2019). EVALUATION OF SINGLE DOSE SODIUM POLYSTYRENE SULFONATE FOR MANAGEMENT OF HYPERKALEMIA AND ITS EFFECT ON OTHER SERUM ELECTROLYTES. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Hood, Simon, Gemma A. Foulds, Heather Imrie, et al.. (2019). Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation. Frontiers in Immunology. 9. 3169–3169. 21 indexed citations
6.
Cosma, Georgina, Giovanni Acampora, David J. Brown, et al.. (2016). Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model. PLoS ONE. 11(6). e0155856–e0155856. 44 indexed citations
7.
Mellon, J. Kilian, et al.. (2013). The emerging role of transperineal template prostate biopsy in patients with a persistently raised PSA despite one negative TRUS-guided prostate biopsy. International Journal of Surgery. 11(8). 727–727. 1 indexed citations
8.
Pal, Raj P., et al.. (2013). Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies. World Journal of Urology. 32(4). 971–975. 9 indexed citations
9.
Pal, Raj P., et al.. (2012). Defining prostate cancer risk before prostate biopsy. Urologic Oncology Seminars and Original Investigations. 31(8). 1408–1418. 23 indexed citations
10.
Lee, George, et al.. (2010). The role of embolization in the management of tumour recurrence after radical nephrectomy. British Journal of Hospital Medicine. 71(1). 52–52. 2 indexed citations
11.
Bright, Elizabeth, et al.. (2009). Incidence and Factors Predicting the Detection of Prostate Cancer after Transurethral Resection of the Prostate for Clinically Benign Disease. Urologia Internationalis. 83(2). 171–174. 8 indexed citations
12.
Khan, Masood A. & Alan W. Partin. (2005). Surgical margin status after radical retropubic prostatectomy. British Journal of Urology. 95(3). 281–284. 12 indexed citations
13.
Veltri, Robert W., Masood A. Khan, Michael Craig Miller, et al.. (2004). Ability to Predict Metastasis Based On Pathology Findings and Alterations in Nuclear Structure Of Normal-Appearing and Cancer Peripheral Zone Epithelium in the Prostate. Clinical Cancer Research. 10(10). 3465–3473. 44 indexed citations
14.
Khan, Masood A., Michael A. Carducci, & Alan W. Partin. (2004). Docetaxel in androgen‐independent prostate cancer: an update. British Journal of Urology. 94(9). 1209–1210. 5 indexed citations
15.
Rogers, Craig, Masood A. Khan, Michael Craig Miller, Robert W. Veltri, & Alan W. Partin. (2004). Natural history of disease progression in patients who fail to achieve an undetectable prostate‐specific antigen level after undergoing radical prostatectomy. Cancer. 101(11). 2549–2556. 58 indexed citations
16.
Khan, Masood A., Alan W. Partin, & H.Ballentine Carter. (2003). Expectant management of localized prostate cancer. Urology. 62(5). 793–799. 9 indexed citations
17.
Khan, Masood A., Alan W. Partin, Leslie A. Mangold, Jonathan I. Epstein, & Patrick C. Walsh. (2003). Probability of biochemical recurrence by analysis of pathologic stage, gleason score, and margin status for localized prostate cancer. Urology. 62(5). 866–871. 65 indexed citations
18.
Khan, Masood A., Alan W. Partin, Harry G. Rittenhouse, et al.. (2003). Evaluation of Proprostate Specific Antigen for Early Detection of Prostate Cancer in Men With a Total Prostate Specific Antigen Range of 4.0 to 10.0 Ng/Ml. The Journal of Urology. 170(3). 723–726. 65 indexed citations
19.
Khan, Masood A., H. Ballentine Carter, Jonathan I. Epstein, et al.. (2003). Can Prostate Specific Antigen Derivatives and Pathological Parameters Predict Significant Change in Expectant Management Criteria for Prostate Cancer?. The Journal of Urology. 170(6). 2274–2278. 61 indexed citations
20.
Khan, Masood A., Misop Han, Alan W. Partin, Jonathan I. Epstein, & Patrick C. Walsh. (2003). Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology. 62(1). 86–91. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ugo Giovanni Falagario Breakdown of academic impact, for papers by Pieter De Visschere Breakdown of academic impact, for papers by Sanoj Punnen Breakdown of academic impact, for papers by Peter Swindle Breakdown of academic impact, for papers by Paula Kujala Breakdown of academic impact, for papers by Nelly Tan Breakdown of academic impact, for papers by Kerri Cote Breakdown of academic impact, for papers by Seungtaek Choi Breakdown of academic impact, for papers by John J. Bauer Breakdown of academic impact, for papers by John Foley
Rankless by CCL
2026